The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition.
Learn more orphan products.
Recombinant human luteinizing hormone
(Brand name: Luveris® (injection))
- Manufactured by EMD Serono, Inc.
FDA-approved indication: Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hypogonadal women with profound LH deficiency (LH (less than) 1.2 IU/L).
National Library of Medicine Drug Information Portal